X4 Pharmaceuticals
XFOR
XFOR
97 hedge funds and large institutions have $67.3M invested in X4 Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
0.03% less ownership
Funds ownership: 2.02% → 1.99% (-0.03%)
1% less funds holding
Funds holding: 98 → 97 (-1)
Holders
97
Holding in Top 10
1
Calls
$279K
Puts
$106K
Top Buyers
| 1 | +$954K | |
| 2 | +$436K | |
| 3 | +$358K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$340K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$260K |
Top Sellers
| 1 | -$2.35M | |
| 2 | -$801K | |
| 3 | -$382K | |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$268K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$132K |